Drug Profile
HBN 2
Latest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Hibernaid
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Brain injuries; Hot flashes; Progeria
Most Recent Events
- 31 Aug 2023 Discontinued - Clinical-Phase-Unknown for Progeria in USA (PO)
- 31 Aug 2023 Discontinued - Preclinical for Hot flashes in USA (PO)
- 31 Aug 2023 Discontinued for Brain injuries in USA (PO)